跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 92,888 条关于
“HER2-driven cancers”
全部
92,888
临床试验
75,814
药物
2,453
机构
343
资讯
14,278
11个月前
Debiopharm Advances Bispecific ADC Development with SunRock Biopharma's Anti-HER2/HER3 Antibody License
去年
Lung Cancer Research Foundation and Boehringer Ingelheim Launch $2.25 Million Initiative to Target HER2-Mutant Lung Cancer
7个月前
GSK and Hansoh Pharma Advance Next-Generation HER2-Targeted ADC GSK5764227 in Early Clinical Trials
去年
FDA Approves Zanidatamab (Ziihera®) for HER2-Positive Biliary Tract Cancers
去年
FDA Approves 420-mg Dosage of Trastuzumab-strf Biosimilar for HER2-Overexpressing Cancers
去年
Meta-Analysis Confirms Trastuzumab Deruxtecan Efficacy in HER2-Positive Gastrointestinal Cancers
10个月前
Two Novel Tumor-Agnostic Trials Target HER2-Positive Cancers and p53 Mutations at ESMO 2024
上个月
Iterion Therapeutics Strengthens Board as Tegavivint Expands Across Wnt-Driven Cancers
3年前
Trastuzumab Deruxtecan Gains Regulatory Approvals in China and Europe for HER2-Positive Cancers
2年前
T-DXd Combinations Show Promise in HER2+ Gastric and GEJ Cancers
第 1 页,共 1428 页
上一页
下一页